Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal insulin comparison of glucose production, lipolysis, and proteolysis in type 2 diabetes
NL-OMON24652Not yet recruiting
- Sponsor
- Academic Pharmaceuticals
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of insulin isophane, insulin detemir and insulin glargine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Academic Pharmaceuticals. Primary endpoints: Hepatic glucose production, Lipolysis and 1 more. Planned start Aug 2007; status: not yet recruiting.
02
Drugs
insulin isophaneinsulin detemirinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON24652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24652.